
Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail Specialists
Author(s) -
Shari R. Lipner,
Mahmoud Ghannoum,
Molly Hinshaw,
Phoebe Rich,
Beth S. Ruben,
Stephen M. Schleicher,
Richard K. Scher
Publication year - 2021
Publication title -
skin appendage disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.773
H-Index - 13
eISSN - 2296-9195
pISSN - 2296-9160
DOI - 10.1159/000520628
Subject(s) - podiatrist , nail (fastener) , covid-19 , pandemic , medicine , multidisciplinary approach , sampling (signal processing) , dermatopathology , dermatology , pathology , surgery , disease , engineering , infectious disease (medical specialty) , mechanical engineering , social science , filter (signal processing) , sociology , outbreak , complication , electrical engineering
Onychomycosis is the most common nail condition seen in clinical practice, with significant impact on quality of life. Clinical examination alone is insufficient for accurate diagnosis, but mycological confirmation can be challenging during the COVID-19 pandemic. In this letter, a multidisciplinary panel of dermatologists, a podiatrist, dermatopathologists, and a mycologist, discuss considerations for mycological sampling during the pandemic.